Even artificial Intelligence loves our CF33 game changing asset, amazing how simply it explains it!
"CF33 is an oncolytic virus that is being studied as a potential cancer treatment. An oncolytic virus is a type of virus that can selectively infect and kill cancer cells, while leaving healthy cells unharmed. CF33 is a modified form of the common cold virus, called the adenovirus, that has been engineered to target and destroy cancer cells.
When the CF33 virus infects a cancer cell, it replicates and eventually causes the cancer cell to burst, releasing new virus particles that can infect and kill more cancer cells. This can potentially lead to the shrinkage or elimination of tumors in the body.
CF33 is still undergoing clinical trials to determine its safety and effectiveness as a cancer treatment. While the results so far have been promising, more research is needed before it can be widely used as a treatment option.
- Forums
- ASX - By Stock
- IMU
- The CF33, Vaxinia and Oncarlytics Deal
IMU
imugene limited
Add to My Watchlist
7.69%
!
1.2¢

The CF33, Vaxinia and Oncarlytics Deal, page-287
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $89.60M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.2¢ | $140.7K | 11.61M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
50 | 9000852 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 6923007 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
49 | 8984186 | 0.012 |
49 | 12950641 | 0.011 |
67 | 25218374 | 0.010 |
17 | 3643042 | 0.009 |
9 | 2663499 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 6923007 | 25 |
0.014 | 7952040 | 31 |
0.015 | 8596367 | 30 |
0.016 | 7393011 | 30 |
0.017 | 12265156 | 16 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |